Stockholm-based healthtech company Neko Health has successfully raised $700 million in Series C funding, significantly boosting its valuation from $1.7 billion to nearly $7 billion. Founded by Spotify co-founder Daniel Ek, Neko focuses on early disease detection and prevention through innovative medical scanning technology. Their flagship offering is a non-invasive, 60-minute body scan that assesses various health metrics at a cost of £299 in the UK and 2,750 SEK in Sweden.
The recent funding round, led by Lightspeed Venture Partners, included investments from tech luminaries like Mark Zuckerberg and celebrities like Maria Sharapova. Positioned at the intersection of AI and healthcare, Neko plans to expand into the U.S. market with its first clinics in New York later this year, having already received FDA clearance for several products. The company aims to address complex healthcare needs, with over 350,000 individuals on a waiting list to access its services.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://ventureburn.com/daniel-ek-neko-health-raises-700-million-preventive-tech/
